Come up with a name for your new list and we'll add to it:
Pinteon Therapeutics raised a round of funding on July 22, 2014. Investors include
Morningside Group (晨兴集团).
Pinteon Therapeutics is a biotechnology company focused on the discovery and development of breakthrough therapeutics targeting Pin1. Pin1 acts as a central regulator in cancer development and growth …